1. Introduction
===============

Acquired Immune Deficiency Syndrome (AIDS), tuberculosis, and malaria are known as the original hazardous diseases for public health ([@b1-epj-09-5920]). Due to its devastating impact on the community, AIDS has recently come under the spotlight ([@b2-epj-09-5920]). The complex and multidimensional nature of this disease has made its management difficult ([@b3-epj-09-5920]). Centre for Disease Control and Prevention (CDC) of the United States has offered to use integrated information systems to tackle this disease more efficiently ([@b4-epj-09-5920]). In this regard, creating complex and coordinated templates for recording and reporting data on the disease in the form of a Standard Minimum Data Set (MDS) is an essential prerequisite for the integrated systems of information exchange on AIDS ([@b4-epj-09-5920], [@b5-epj-09-5920]). A workgroup comprising of global informatics medical specialists, clinical specialists of AIDS, and decision and policy-makers has achieved a consensus about the necessity of creating the MDS templates to manage and monitor treatment programmes for AIDS in developing countries ([@b6-epj-09-5920]). The MDS is a standard method to gather, store and distribute key and standard data elements ([@b7-epj-09-5920]). Creating and designing systematic MDS is one of the first and most basic steps in the creation and foundation of the national information system and improving the communication between individuals and organizations involved in the care ([@b8-epj-09-5920]). The MDS is not only limited to particular clinical and care affairs of AIDS but is also used to facilitate managerial decision and policy-making aspects, research aspects, performance management, quality and financial improvement and reimbursement ([@b6-epj-09-5920]). Iran, like many other countries, has a strategic national plan to control and manage AIDS ([@b9-epj-09-5920]). However, the prevalence of AIDS is still high ([@b2-epj-09-5920], [@b10-epj-09-5920], [@b11-epj-09-5920]) and the effective control and management process for this disease is facing many challenges ([@b2-epj-09-5920], [@b9-epj-09-5920]). One of the most important challenges is the insufficient attention to supportive and consulting programmes, and lack of information (especially accurate statistics) for decision and policy-makings ([@b2-epj-09-5920]). In one of the paragraphs of the national strategic programmes against AIDS in Iran, it emphasized on the creation of an integrated structure to collect, register, analyze and integrate distribution of information among all individuals, groups and relevant organizations ([@b12-epj-09-5920]). Thus, creating a monolithic and comprehensive framework, which considers the information needs of all beneficiaries, is necessary.

2. Material and Methods
=======================

In order to identify essential data elements for reporting information on clinical and managerial aspects of AIDS, a systematic review approach was used. The study was performed in 4 steps: 1) Designing and implementing search strategies, 2) Collection of related articles by inclusion or exclusion criteria, 3) Selection of final related articles, and 4) Content analysis of information.

2.1. Design and implementing search strategies
----------------------------------------------

This study was carried out in 2017. The keywords presenting the MDS application of AIDS that were implemented in HIV/AIDS EMR, surveillance, registry and data base systems, were used in order to carry out the search. Required keywords were selected from the official PubMed website using the Mesh database and then several databases such as Web of Science, ScienceDirect, Scopus, PubMed, and Google Scholar search engine were searched based on the associated techniques of each database ([Table 1](#t1-epj-09-5920){ref-type="table"}). By selecting the search option in the title, abstract and keywords of the Scopus and Science Direct database, title and abstract in PubMed, and subject in Web of Science database and Google Scholar search engine, and finally implementing the input and output criteria and using the advanced search option, 25, 38, 22, 38, and 98 articles were selected as the final articles from the named databases, respectively. In [Table 1](#t1-epj-09-5920){ref-type="table"}, the systematic search strategy is proposed in a search field format for each of the databases.

2.2. The inclusion/exclusion criteria
-------------------------------------

This research includes all full-text articles extracted from reliable sources in English between the years 2000 and 2016. Short articles, letters to the editor, accepted papers in conferences and reports extracted from blogs were not included in this study. The main criterion for selection of research articles was the content association of the articles with the research title. Due to the limited number of available research articles on the MDS of AIDS, several criteria were considered for selecting articles that have introduced necessary data elements for reporting AIDS. So, after searching with the keywords and the implementation of inclusion and exclusion criteria, titles with at least three of the following data classes related to the main objectives of reporting of AIDS were selected: 1. Medical and clinical (primary objectives), 2. Administrative and managerial (secondary objectives) and 3. Supportive purposes (primary and secondary objectives). A search of resources and evaluation of the articles findings resulted in data enrichment such that all categories, classes, and data elements in the resources were available. Thus, there is no need for further contact with the authors of the articles.

2.3. Choosing related articles to enter the study
-------------------------------------------------

A total number of 223 articles were selected and entered into the EndNote software. After duplicates were eliminated, 112 articles were obtained. By examining titles, 58 were selected as relevant to our study and after reviewing the abstracts and the theses, 28 articles were selected for inclusion into the study, as demonstrated in [Figure 1](#f1-epj-09-5920){ref-type="fig"}.

2.4. Research Tools
-------------------

In this study, in order to extract data elements required for reporting AIDS from related articles, a data extraction checklist was used, which included the following categories: titles of articles, the authors' names, years of publication, article sources (including journals, conference presentation), and the method of the study. In addition, it contained a column for presenting research findings, in which the ones that contained at least three essential data classes for reporting AIDS with primary or secondary objectives were included. The form was designed by the researcher and was also based on research objectives that were used after the confirmation of its content validity by three experts. The research variables in this study are divided into three general groups including data categories (general level), data classes (detailed level) and data elements (atomic level). Among the collection of retrieved data, those articles were chosen which had at least one data class for each of the three-fold data categories. By evaluating the articles, each of the three-fold data levels above were extracted and categorized and with regard to the input and output criteria, they were entered into the data extraction form.

2.5. Analysis of results
------------------------

In order to analyze the data, content analysis was used, which is a method to identify, analyze and report themes in the text, and has great applications in analysis of qualitative data ([@b13-epj-09-5920]).

3. Results
==========

As many as 28 papers were included in the present study, five of them were directly about the MDS of AIDS, six about the EMR of AIDS, nine articles were about the surveillance systems of AIDS, one about the database of AIDS, three articles were about public health reporting systems and four about the clinical document exchange formats (e.g. Clinical Document Architecture \[CDA\] and Continue Care Document \[CCD\]) of AIDS. [Figure 2](#f2-epj-09-5920){ref-type="fig"} categorises the studies by subjects. In the following, a summary of results obtained from the systematic review in 3.2. Section ([Table 2](#t2-epj-09-5920){ref-type="table"}) along with identified information classes and data elements in 3.3. section ([Tables 3](#t3-epj-09-5920){ref-type="table"}[](#t4-epj-09-5920){ref-type="table"}--[5](#t5-epj-09-5920){ref-type="table"}) is put forth. The results classified data classes and data elements necessary for HIV reporting system in three general categories: 1) Management, administrative and policy-making purposes ([Table 3](#t3-epj-09-5920){ref-type="table"}), 2) Medical and clinical purposes ([Table 4](#t4-epj-09-5920){ref-type="table"}), and 3) Supporting purposes (primary and secondary) ([Table 5](#t5-epj-09-5920){ref-type="table"}). Demographic information was the most frequent data class for the systemic reporting of AIDS for administrative, management and policy-making purposes that were mentioned in 23 articles. Among the demographic data elements, patient name/surname, age, sex and race were the most frequent items. In the field of financial and reimbursement reporting, data elements of the method of payment (patient self-pay, financial intermediaries, charities and other payment sources) ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b29-epj-09-5920], [@b36-epj-09-5920]) and the type of insurance coverage (public, private) ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b29-epj-09-5920], [@b32-epj-09-5920], [@b36-epj-09-5920]) were of great importance. Unpopular sexual orientation (gay, unbridled/multiple sex, unsafe sex and transsexualism) ([@b18-epj-09-5920], [@b29-epj-09-5920]--[@b31-epj-09-5920], [@b39-epj-09-5920]), repeated transfusions of blood and blood products ([@b18-epj-09-5920], [@b29-epj-09-5920]--[@b31-epj-09-5920]), and alcoholism and drug abuse ([@b6-epj-09-5920], [@b19-epj-09-5920], [@b29-epj-09-5920]--[@b31-epj-09-5920]) were three of the most important data elements in identifying vulnerable groups and determining types of disease transmissions, which can improve the process of managing and controlling the disease. Socio-economic information was another important class for the MDS of AIDS. Among its subgroups, factors such as type of occupation as there is more exposure to diseases in certain jobs (healthcare providers, hairdressers, immigrant workers) ([@b16-epj-09-5920], [@b17-epj-09-5920], [@b19-epj-09-5920], [@b20-epj-09-5920], [@b38-epj-09-5920]) and marital status (single, married, widowed or separated) ([@b16-epj-09-5920], [@b19-epj-09-5920]--[@b21-epj-09-5920], [@b23-epj-09-5920], [@b29-epj-09-5920], [@b33-epj-09-5920], [@b39-epj-09-5920]) were also introduced as important data elements in AIDS reporting processes. The importance of privacy and confidentiality on the AIDS information exchange is higher than that of many other diseases. One of the most important parts in any reporting system is its legal aspect. Receiving consent from patients is critical, especially in the field of the disclosure of information. In this regard, the data element of the confidentiality code([@b17-epj-09-5920]) and the profile of the authorized sender and recipient ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920]) are important. Another effective element to maintain the privacy and confidentiality of the information in patient reports is the data elements of unique identifiers. ([@b19-epj-09-5920], [@b20-epj-09-5920], [@b23-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b40-epj-09-5920]). AIDS-specific tests (HIV antibody, Cluster of Differentiation 4 (CD4) and Cluster of Differentiation 8 (CD8) counts, and viral load testing) ([@b6-epj-09-5920], [@b17-epj-09-5920], [@b20-epj-09-5920], [@b22-epj-09-5920], [@b26-epj-09-5920]--[@b28-epj-09-5920], [@b30-epj-09-5920], [@b35-epj-09-5920], [@b37-epj-09-5920]) are the most important data elements for reporting laboratory status of AIDS. AIDS-related drug administrations (Anti Retrovirus Therapy (ART), Anti Retrovirus ARV (prevention) and Co-trim oxazole \[prevention\]) ([@b6-epj-09-5920], [@b19-epj-09-5920]--[@b22-epj-09-5920], [@b26-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920]) are essential in reporting conditions associated with administration. In many studies, the importance of determining the class of AIDS (four classes set by WHO) ([@b6-epj-09-5920], [@b20-epj-09-5920]--[@b22-epj-09-5920], [@b27-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920], [@b39-epj-09-5920]) is emphasized in order for reporting. Information class of the patient's history is also necessary for identifying the data elements of AIDS MDS from two aspects of the clinical (primary goals) and the nonclinical (secondary goals). For example, data elements of history of disease (related or unrelated to AIDS) ([@b3-epj-09-5920], [@b6-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b23-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b34-epj-09-5920], [@b39-epj-09-5920]) are important for reporting with the primary care purposes, and social history (social class, chaos, leaning towards drugs) ([@b20-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b36-epj-09-5920]) are important for reporting with the secondary care purposes. Determining the disposition of the patient is an important data class for improving the treatment plans, among which the referral/transfer information (type, cause, date and place before or after referral/transfer( ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b28-epj-09-5920], [@b31-epj-09-5920], [@b33-epj-09-5920], [@b38-epj-09-5920], [@b40-epj-09-5920]), admission/discharge information (type, cause, date, place before or after admission/discharge) ([@b6-epj-09-5920], [@b24-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b36-epj-09-5920]), as well as the location of the patient's referral/ transfer (hospital, emergency, specialized clinics, medical offices, counselling/support, outpatient services and public health organizations) ([@b18-epj-09-5920], [@b39-epj-09-5920]) are data elements necessary for identifying the MDS of AIDS. Consultation with the primary objectives ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b34-epj-09-5920], [@b40-epj-09-5920]) which is directly related to care and treatment, and consultation with secondary objectives ([@b20-epj-09-5920], [@b34-epj-09-5920], [@b40-epj-09-5920]) that indirectly affect the care and treatment, are of the most prominent data elements of reporting with supportive purposes.

4. Discussion
=============

4.1. The horizon ahead for Iran
-------------------------------

The reasons behind why the prevalence of AIDS is high in Iran is the country being located beside the biggest narcotic transportation in the world in neighbouring Afghanistan and the high incidence of the disease in its northern neighbour -- Turkmenistan ([@b2-epj-09-5920]). Additionally, in recent years, an increase in the amount of infection by sexual contact (especially among youngsters) has also fuelled this problem ([@b11-epj-09-5920]). The foundation of reporting systems of conditions associated with AIDS in Iran is known as one of the basic requirements to control and manage this disease ([@b10-epj-09-5920]). The PHIE systems in the form of bilinear reporting systems, among all beneficiaries involved in control and management of AIDS disease at local and national level, can play a great role in the inhibition of this disease ([@b9-epj-09-5920]). A study by Lai et al. (2008) showed that the use of the MDS of AIDS improves care by effective information exchange, and changes the traditional interactions between the teams involved in the care ([@b41-epj-09-5920]). The integrated AIDS care system consists of various parts of the health care industry including hospitals and other healthcare provider organizations, supportive and subsidiary service providers, public health, government, legislators, policy-makers and reimbursement agencies ([@b6-epj-09-5920]). Providing a comprehensive MDS that can meet the needs of all individuals and associated groups is the essential prerequisite of an integrated system of AIDS information exchange ([@b42-epj-09-5920], [@b6-epj-09-5920]). AIDS treatment and care programmes in Iran offer a good level of services, but the challenge lies in the insufficient attention to supportive and counselling programmes, as well as the lack of information for making an accurate and efficient decision and policy ([@b2-epj-09-5920]). These deficiencies should be considered in the design of the MDS of integrated data reporting of AIDS, and the needs of all the involved groups should be considered as unified ([@b6-epj-09-5920], [@b2-epj-09-5920]). The coverage of proposed data elements, as reviewed in the studies, are generally limited to medical and diagnostic domains, and the needs of secondary care, supportive and counselling activities have been rarely considered. For example, Tierney et al. (2006) have prioritised the needs of care professionals (doctors, nurses and paramedics) to the needs of managers and administrative staff, agencies and legislatures, policy-makers, reimbursement agencies, researchers and support institutions for the design of the MDS of AIDS) ([@b6-epj-09-5920], [@b40-epj-09-5920]). In Iran, due to the specific social, cultural and religious characteristics, people often think of AIDS as a stigma caused by sex outside marriage ([@b11-epj-09-5920]); Most patients in this situation will not be willing to undergo tests and follow their treatment, and they will not be notified until the progression and appearance of the symptoms of disease ([@b2-epj-09-5920]). The exact prevalence rate of AIDS is unclear in Iran due to long concealment of the disease because of the mass reluctance to carry out consultations and diagnostic tests ([@b10-epj-09-5920]). The disease has also profound effects on the physical, mental, spiritual, family and job functions, as well as the social and economic statuses of individuals ([@b43-epj-09-5920]); So, there is a greater need for protective measures, counselling programmes, awareness and education (especially before and after the first test, at the time of positive result and during the treatment process) ([@b2-epj-09-5920]). In this study, one of the three goals of reporting AIDS is related to support. Data classes, associated with it, are crafted in three parts: consulting, supportive and subsidiary services. Health, social, economic, and demographic statuses affect the pattern of AIDS in countries. Social participation, the physical and mental performance of individuals, disability (physical or mental), social security services, and immigration status can be useful for monitoring and evaluation system of AIDS ([@b44-epj-09-5920]). In a study conducted by Morgan (2012), social records such as employment status, marital status, lifestyle, moral status, leaning towards drugs and alcohol, housing and protection system (guardian) are mentioned as necessary data elements for facilitating policy and decision-making processes ([@b29-epj-09-5920]). In this study, in addition to the application of data elements for the improvement of healthcare (primary objective), the secondary needs (administrative, management, and policy-making) have also been considered. Hence, the decision and policy-making activities against AIDS in Iran can be improved with the elimination of the available information shortage ([@b45-epj-09-5920], [@b2-epj-09-5920]). Therefore, in the designed MDS, an attempt was made to consider the existing deficiencies in a comprehensive care programme for AIDS in Iran (especially in the secondary objectives of care). In addition, a comprehensive data set has been provided for medical and diagnostic procedure and support programmes, in order for continuous and patient-oriented treatment.

4.2. The strengths of the suggested MDS
---------------------------------------

Mirzaee et al. (2013) examined the types of HIV transmission in large surveillance systems to identify at-risk groups in Iran ([@b46-epj-09-5920]). The present study has considered the data elements of transmission and at-risk groups, important for care and policy-making objectives ([Table 3](#t3-epj-09-5920){ref-type="table"}). In two studies conducted by Patra et al. (2010) (2011), on the creation of CDA for AIDS, data elements were structured in two parts: CDA title (meta information about the document) and on the other hand, CDA body (narrative information) ([@b27-epj-09-5920], [@b28-epj-09-5920]). In the present study, offering MDS in two categories of nonclinical data classes (demographic, identification and document information classes) for CDA title and clinical (diagnostic, prescriptive, laboratory, history) for CDA body, has become a necessary prerequisite for CDA template designing ([Tables 3](#t3-epj-09-5920){ref-type="table"}, [4](#t4-epj-09-5920){ref-type="table"}). About 80% of the cases, monitored for epidemic HIV disease in the community, need laboratory interventions ([@b47-epj-09-5920]). One of the most important technological infrastructures, used in public health reports, is the use of an Electronic Laboratory Reporting (ELR) system. The basic prerequisite for this infrastructure is the complete and standard definition of laboratory data elements ([@b48-epj-09-5920]). In the present study, laboratory data are introduced as the most important elements for reporting AIDS, and it was planned to be designed in such a way that the ELR needs could be met ([Table 4](#t4-epj-09-5920){ref-type="table"}). One of the challenges facing the early diagnosis of patients with AIDS in Iran and persuading them to actively participate in the management of their treatment, is fear of information disclosure and honour endangerment ([@b2-epj-09-5920]). Thus, in the current study, another attempt was made to consider the requirement of confidentiality and security of information in the design of the MDS. This requirement has been met via the legal information class (different consents and codes of confidentiality of information), document information class (profile of the authorized receiver and transmitter) and unique identification information class ([Table 3](#t3-epj-09-5920){ref-type="table"}). Rosen et al. (2016) evaluated the information of the ART prescription, including scheduling, assessments of adherence, qualifying the receipt and history of it regarding the level of CD4. These two were introduced as complementary to each other for advanced analyses ([@b49-epj-09-5920]). The role of prescribing information, especially the ART, was great for reporting in this study ([Table 4](#t4-epj-09-5920){ref-type="table"}). Palla et al. (2006) reviewed the cause of death due to AIDS (direct and indirect). They noticed over time a change in the pattern of the cause of death due to AIDS ([@b50-epj-09-5920]). In the present study, this obligation was fully predicted in the overall category of survival status information class ([Table 3](#t3-epj-09-5920){ref-type="table"}).

4.3. The weaknesses of the proposed MDS
---------------------------------------

Determining the type of antiretroviral treatment, failure can be defined as a less than desirable response to treatment. These types of failures include virology, immunology, and clinical failure. Reporting this situation in the AIDS reports is useful for clinical evaluations ([@b51-epj-09-5920]). Unfortunately, in the current study, none mentioned this information class. Elements of the pregnancy status in HIV reporting include information of previous pregnancy/pregnancy history, date of last menstrual period, estimated delivery time, gestational age, pregnancy/gestational planning and contraception ([@b20-epj-09-5920], [@b34-epj-09-5920], [@b40-epj-09-5920]) required to be evaluated in a separate data class for the medical/clinical purposes in this study.

5. Conclusions
==============

The designed MDS in the present study considers the HIV reporting system in three main categories: 1. Medical and clinical, 2. Management, administrative, and policy-making, and 3. Consulting, supportive, and subsidiary services. The designed data framework makes it possible to overcome the problems of the comprehensive system of AIDS treatment and management in Iran. However, its prerequisite, and standardizing content and the structure of data messages in the form of messaging protocols in the network for optimum interoperability, is essential.
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###### 

Search strategy details

  Name of Database   Search Fields
  ------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Scopus             ABS-KEY ("Minimum Data Set" ) OR TITLE-ABS-KEY ("Core Data Set ") OR TITLE-ABS-KEY ("Minimum Data Element ") OR TITLE-ABS-KEY ("Essential Data Set ") OR TITLE-ABS-KEY ("Essential Data Element " ) OR TITLE-ABS-KEY ("Core Data Element ") AND TITLE-ABS-KEY (AIDS) OR TITLE-ABS-KEY (HIV) AND TITLE-ABS-KEY (Report\*) AND (LIMIT-TO (LANGUAGE, "English" )) AND (LIMIT-TO (2000--2016))
  Science Direct     TITLE-ABS-KEY ("Minimum Data Set" OR "Core Data Set" OR "Minimum Data Element" OR "Core Data Element" OR "Essential Data Set" OR "Essential Data Element") and TITLE-ABS-KEY (HIV OR AIDS) and TITLE-ABS-KEY (Report\*) AND LANGUAGE: (English), limited to 2000--2016.
  Web of Science     TC=("Minimum Data Set" OR "Core Data Set" OR "Minimum Data Element" OR "Core Data Element" OR "Essential Data Set" OR "Essential Data Element") AND TC=(HIV OR AIDS) AND TC=( Report\*) AND LANGUAGE: (English), limited to 2000--2016.
  PubMed             (((((((((((((("Minimum Data Set "\[Title/ Abstract\]) OR "Core Data Set "\[ Title/ Abstract\]) OR "Core Data Element "\[ Title/ Abstract\]) OR "Minimum Data Element "\[ Title/ Abstract\]) OR "Essential Data Set "\[ Title/ Abstract\]) OR "Essential Data Element "\[ Title/ Abstract\]) AND HIV \[Title/ Abstract\]) OR AIDS \[Title/ Abstract\]) AND Report\* \[ Title/ Abstract\]))) AND (English\[lang\]), limited to 2000--2016.
  Google Scholar     Minimum Data Set " OR " Core Data Set " OR "Minimum Data Element" OR "Core Data Element" OR "Essential Data Set" OR "Essential Data Element" AND "AIDS" OR "HIV" AND report\* AND English\[lang\], limited to 2000--2016.

###### 

Characteristics and results of final studies entering the research

  Ref. no.             Method                                                                                                                        Finding
  -------------------- ----------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@b14-epj-09-5920]   Analysing admission assessments                                                                                               Sociodemographic characteristics, health status measures and special treatments or procedures received
  [@b18-epj-09-5920]   Information were abstracted from AIDS cases reported in the United States                                                     Demographic, Diagnostic, Supportive and Consulting, Laboratory, Comorbidities, Prescriptive, History, Survival status, transmission category and High risk groups Data Sets
  [@b16-epj-09-5920]   Analysis of AIDS Case Report and Incidence Trend                                                                              Sociodemographic specifications and Clinical or health status
  [@b17-epj-09-5920]   Descriptive Approach                                                                                                          Sociodemographic, Administrative, Clinical and Supportive Data Sets
  [@b18-epj-09-5920]   Assessment USA AIDS Case Reports (1981 -- 2002)                                                                               Sociodemographic, Diagnostic, High risk or vulnerable groups and Utilization Healthcare Data Sets
  [@b19-epj-09-5920]   Medical documentation and AIDS Reports forms review                                                                           Sociodemographic, Identification, Clinical or Diagnostic and High risk or vulnerable groups Data Sets
  [@b12-epj-09-5920]   Cross sectional Cohort Study                                                                                                  Demographic, Socio-economic, Identification, Diagnostic, Supportive and Consulting, Laboratory, Prescriptive, History, Survival status and Pregnancy status Data Sets
  [@b6-epj-09-5920]    Expert panel                                                                                                                  Demographics, History, Physical examination, Laboratory: HIV specific, Laboratory: HIV monitoring and Imaging Data Sets
  [@b21-epj-09-5920]   Cohort Analysis                                                                                                               Demographic, HIV care and family status, ART summary and Patient encounter Data Sets
  [@b22-epj-09-5920]   Data sets was derived from AIDS data base                                                                                     Demographic, Encounter, Diagnostic, Laboratory, drug regimens, health history, laboratory, clinical history and transmission category Data Sets
  [@b23-epj-09-5920]   Literature review and Survey methodology                                                                                      Patient identifier, Patient contact, Problems of the patient, Responsible organization or personnel Data Sets
  [@b24-epj-09-5920]   Content Analysis                                                                                                              Patient demographics, location, clinical, Diagnostic, Medications, Subject, Healthcare provider and Reporting Data Sets
  [@b25-epj-09-5920]   Survey methodology                                                                                                            Patient demographics, diagnoses, prescription, and lab test results Data Sets
  [@b26-epj-09-5920]   Information were captured by the Guyana's national HIV patient monitoring system                                              Patient chart, Pre-ART patient register and ART patient register Data Sets
  [@b27-epj-09-5920]   Case study                                                                                                                    Demographic, identifier, Contact, document and Clinical or Diagnostic Data Sets.
  [@b28-epj-09-5920]   Data Sets was Derived from the AIDS Standard guidelines and knowledge bases                                                   Demographic information, HIV care and family status, ART summary and patient encounter Data Sets
  [@b29-epj-09-5920]   Data Sets was Retrieved from the united states surveillance and Registry systems                                              Demographic, Socio-economic, Identification, Administrative and policy, Clinical and Diagnostic, Supportive and Consulting, Laboratory tests, Prescriptive, History, Survival status and Comorbidities Data Sets
  [@b30-epj-09-5920]   Internet Report                                                                                                               Demographics, Eligibility (Financial and Insurance), Medical (Basic, History and Pregnancy), Medication, Risk Assessment and Services Data Sets
  [@b31-epj-09-5920]   Descriptive study                                                                                                             Demographic, Medical, Screening, Complementary and Warning conditions Data Sets
  [@b32-epj-09-5920]   Qualitative (Content analysis and thematically analysis) and quantitative (descriptive and multivariate statistics) methods   Member Details, Healthcare and Care Coordination Providers, Medications, Result, Payer and Document Data Sets
  [@b33-epj-09-5920]   Combination of qualitative (Content analysis) and quantitative (survey) methods                                               Demographic, Clinical and Diagnostic, History, Laboratory and Imaging Procedure, medications
  [@b34-epj-09-5920]   Survey methodology                                                                                                            Patient education and referrals Data Sets, Patient clinic registration, Patients inactivation, Visit registration and triage, Monitoring, Appointment scheduling, Lab, Counselling and Prescription Data Sets
  [@b35-epj-09-5920]   Check the contents of Molecular HIV Surveillance system in United States                                                      Demographic, identifier, Clinical, History, Laboratory and transmission category Data Sets
  [@b36-epj-09-5920]   Public health Case Report Analysing                                                                                           Demographic, identifier, Contact, Diagnostic, History, Laboratory, Prescriptive, financial, Procedures, Immunization and Specimen Data Sets
  [@b37-epj-09-5920]   Evaluation the national HIV viral load testing                                                                                Demographic, Clinical, Laboratory, History and transmission category Data Sets
  [@b38-epj-09-5920]   Combination of qualitative and quantitative methods                                                                           Demographic, identifier, Contact, Diagnostic and Clinical Data Sets
  [@b39-epj-09-5920]   Review of the Sexually transmitted diseases surveillance system in United States                                              Demographic, clinical and behavioural data Sets
  [@b40-epj-09-5920]   Survey methodology                                                                                                            Patients demographics, historical and physical findings, health risk behaviours, tests, diagnoses and treatments Data Sets.

###### 

Necessary Data classes and elements for reporting with management, administrative and policy-making purposes

  Information classes                       Data elements / References
  ----------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Demographic information class             1- Name ([@b6-epj-09-5920], [@b19-epj-09-5920], [@b20-epj-09-5920], [@b23-epj-09-5920]--[@b25-epj-09-5920], [@b28-epj-09-5920], [@b29-epj-09-5920], [@b31-epj-09-5920], [@b33-epj-09-5920], [@b37-epj-09-5920], [@b38-epj-09-5920], [@b40-epj-09-5920]), 2-Surname ([@b6-epj-09-5920], [@b19-epj-09-5920], [@b20-epj-09-5920], [@b22-epj-09-5920], [@b23-epj-09-5920], [@b25-epj-09-5920], [@b28-epj-09-5920], [@b29-epj-09-5920], [@b31-epj-09-5920], [@b33-epj-09-5920], [@b37-epj-09-5920], [@b38-epj-09-5920], [@b40-epj-09-5920]), 3- Father's name ([@b20-epj-09-5920], [@b30-epj-09-5920]), 4- Partner/spouse name ([@b38-epj-09-5920]), 5- Age ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b19-epj-09-5920], [@b23-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b33-epj-09-5920], [@b35-epj-09-5920], [@b37-epj-09-5920]--[@b39-epj-09-5920]), 6- Sex ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b18-epj-09-5920], [@b19-epj-09-5920]--[@b23-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b29-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920], [@b37-epj-09-5920]--[@b39-epj-09-5920]), 7- Race/ethnicity ([@b6-epj-09-5920], [@b15-epj-09-5920], [@b18-epj-09-5920], [@b20-epj-09-5920], [@b23-epj-09-5920], [@b25-epj-09-5920], [@b29-epj-09-5920]--[@b31-epj-09-5920], [@b33-epj-09-5920], [@b35-epj-09-5920], [@b39-epj-09-5920], [@b40-epj-09-5920]), 8- Nationality ([@b6-epj-09-5920], [@b18-epj-09-5920], [@b20-epj-09-5920], [@b23-epj-09-5920], [@b25-epj-09-5920], [@b29-epj-09-5920]--[@b31-epj-09-5920], [@b33-epj-09-5920], [@b35-epj-09-5920], [@b39-epj-09-5920]), 9- Date of birth ([@b6-epj-09-5920], [@b18-epj-09-5920], [@b21-epj-09-5920]--[@b23-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920], [@b37-epj-09-5920], [@b38-epj-09-5920]), 10- Place of birth ([@b6-epj-09-5920], [@b18-epj-09-5920], [@b21-epj-09-5920], [@b22-epj-09-5920], [@b23-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920])
  Contact information class                 1-Address ([@b6-epj-09-5920], [@b23-epj-09-5920], [@b26-epj-09-5920], [@b27-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b36-epj-09-5920], [@b38-epj-09-5920], [@b39-epj-09-5920]), 2-Contact number ([@b20-epj-09-5920], [@b23-epj-09-5920], [@b25-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b36-epj-09-5920]), 3- Postcode/ Zip code ([@b23-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b36-epj-09-5920]), 4- Fax number ([@b36-epj-09-5920]), 5-Email address ([@b29-epj-09-5920], [@b30-epj-09-5920])
  Socio-Economic information class          1- Occupation ([@b16-epj-09-5920], [@b17-epj-09-5920], [@b20-epj-09-5920], [@b22-epj-09-5920]--[@b25-epj-09-5920], [@b38-epj-09-5920], [@b39-epj-09-5920]), 2- Literacy rate ([@b16-epj-09-5920], [@b17-epj-09-5920], [@b19-epj-09-5920], [@b23-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b38-epj-09-5920], [@b39-epj-09-5920]), 3-Health/welfare state ([@b16-epj-09-5920], [@b19-epj-09-5920], [@b29-epj-09-5920], [@b39-epj-09-5920]), 4-Type of residence ([@b16-epj-09-5920], [@b35-epj-09-5920]), 5-Religion ([@b16-epj-09-5920], [@b19-epj-09-5920]), 6-Income ([@b16-epj-09-5920], [@b20-epj-09-5920], [@b23-epj-09-5920], [@b29-epj-09-5920], [@b39-epj-09-5920]), 7-Marital status ([@b16-epj-09-5920], [@b19-epj-09-5920], [@b20-epj-09-5920], [@b22-epj-09-5920], [@b23-epj-09-5920], [@b29-epj-09-5920], [@b33-epj-09-5920]), 8-Social circumstances ([@b19-epj-09-5920], [@b22-epj-09-5920]), 10-Family status ([@b16-epj-09-5920], [@b19-epj-09-5920], [@b20-epj-09-5920], [@b36-epj-09-5920], [@b38-epj-09-5920]), 11-Living situation ([@b16-epj-09-5920], [@b17-epj-09-5920], [@b29-epj-09-5920], [@b35-epj-09-5920], [@b38-epj-09-5920])
  Transmission category information class   1-Injectable drug use ([@b19-epj-09-5920], [@b22-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920]), 2-Sexual relationship ([@b19-epj-09-5920], [@b22-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920]), 3-Mother to child transmission ([@b19-epj-09-5920], [@b22-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920]), 4-Reception of blood and blood products ([@b19-epj-09-5920], [@b22-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920]), 5-Organ transplant ([@b19-epj-09-5920], [@b22-epj-09-5920], [@b26-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920]), 6-Intravenous injection ([@b19-epj-09-5920], [@b22-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920]), 7-Other categories ([@b19-epj-09-5920], [@b22-epj-09-5920], [@b35-epj-09-5920])
  High risk/at risk information class       1-Incorrect sexual orientation ([@b29-epj-09-5920], [@b30-epj-09-5920], [@b39-epj-09-5920]), 2-Receiving blood and blood products ([@b29-epj-09-5920], [@b31-epj-09-5920]), 3-Organ transplantation ([@b29-epj-09-5920], [@b31-epj-09-5920]), 4-Intravascular injection ([@b29-epj-09-5920], [@b31-epj-09-5920]), 5-Alcohol and drug addiction ([@b6-epj-09-5920], [@b19-epj-09-5920], [@b29-epj-09-5920], [@b31-epj-09-5920]), 6-Tattoos ([@b30-epj-09-5920], [@b31-epj-09-5920]), 7-Occupational hazards ([@b30-epj-09-5920], [@b31-epj-09-5920]), 8-Travel/ immigration ([@b26-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920]), 9-Mental disease ([@b30-epj-09-5920]), 10- Other risks ([@b30-epj-09-5920]), 11-Reason of exposure ([@b25-epj-09-5920]), 12-Location of exposure ([@b25-epj-09-5920]), 13- Duration of exposure ([@b25-epj-09-5920]), 14-Date of exposure ([@b25-epj-09-5920]), 15-activity during exposure ([@b25-epj-09-5920])
  Patient disposition information class     1-Referral/transfer info (source, cause, date, place, type) ([@b6-epj-09-5920], [@b21-epj-09-5920], [@b22-epj-09-5920], [@b36-epj-09-5920], [@b40-epj-09-5920]), 2-Follow-up info ([@b25-epj-09-5920], [@b26-epj-09-5920], [@b31-epj-09-5920], [@b36-epj-09-5920]), 3-Admission info (source, cause, date, place, type,) ([@b6-epj-09-5920], [@b21-epj-09-5920], [@b24-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b36-epj-09-5920]), 4- Discharge info (source, cause, date, place, type,) ([@b6-epj-09-5920], [@b21-epj-09-5920], [@b24-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b36-epj-09-5920]), 5-Treatment plans ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b33-epj-09-5920], [@b36-epj-09-5920]), 6-Recommendations at discharge ([@b23-epj-09-5920])
  Financial information class               1- Payment type ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b17-epj-09-5920], [@b32-epj-09-5920]), 2-Payment method ([@b14-epj-09-5920], [@b17-epj-09-5920]), 3-Payment source ([@b6-epj-09-5920]), 4-Policy / coverage type ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b29-epj-09-5920], [@b31-epj-09-5920], [@b36-epj-09-5920]), 5-Insurance name ([@b6-epj-09-5920], [@b32-epj-09-5920]), 6-Insurer company ([@b17-epj-09-5920]), 7-Insurance credit time ([@b17-epj-09-5920]), 8-Payer name ([@b17-epj-09-5920]), 9-covered party ID ([@b32-epj-09-5920]), 10-Member status ([@b17-epj-09-5920])
  Legal information class                   1- Privacy Code ([@b17-epj-09-5920]), 2- Medical/prescription errors ([@b17-epj-09-5920]) Consent for the following purposes: 3-Discharge by personal desire ([@b17-epj-09-5920]), 4- Disclosure of information ([@b17-epj-09-5920])
  Identification information class          Identification number of: 1-Patient ([@b6-epj-09-5920], [@b19-epj-09-5920]--[@b24-epj-09-5920], [@b27-epj-09-5920], [@b33-epj-09-5920], [@b37-epj-09-5920]), 2-Medical record ([@b20-epj-09-5920], [@b23-epj-09-5920], [@b27-epj-09-5920], [@b36-epj-09-5920]), 3-Admission/visit ([@b20-epj-09-5920], [@b27-epj-09-5920]), 4-Treatment/ART therapy ([@b20-epj-09-5920]), 5- Medical specialist ([@b6-epj-09-5920], [@b19-epj-09-5920], [@b20-epj-09-5920], [@b22-epj-09-5920], [@b24-epj-09-5920], [@b26-epj-09-5920], [@b27-epj-09-5920], [@b40-epj-09-5920]), 6- Provider institute ([@b19-epj-09-5920], [@b20-epj-09-5920]--[@b24-epj-09-5920], [@b27-epj-09-5920], [@b37-epj-09-5920], [@b40-epj-09-5920]), 7- Payment ([@b6-epj-09-5920], [@b17-epj-09-5920], [@b32-epj-09-5920]), 8- Specimen([@b24-epj-09-5920], [@b37-epj-09-5920]), 9- Family ([@b6-epj-09-5920], [@b20-epj-09-5920]), 10-Social security ([@b6-epj-09-5920], [@b20-epj-09-5920]), 11-Referral/transfer ([@b20-epj-09-5920])
  Document information class                1- Document name ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920]), 2- Document title ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920]), 3- Document goal ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920]), 4- Document creation date ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920]), 5-Document author ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920]), 6- profile of the authorised transmitter/receiver ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920]), 7- Document description ([@b27-epj-09-5920], [@b28-epj-09-5920], [@b32-epj-09-5920])

###### 

Necessary Data classes and elements for reporting with clinical and medical purposes

  Information classes                                Data elements / References
  -------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Diagnostic information class                       1- Diagnosis finding (related or unrelated to AIDS) ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b19-epj-09-5920], [@b20-epj-09-5920], [@b27-epj-09-5920]--[@b29-epj-09-5920], [@b34-epj-09-5920],[@b39-epj-09-5920]), 2-primary and final diagnosis ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b23-epj-09-5920], [@b24-epj-09-5920], [@b27-epj-09-5920]--[@b29-epj-09-5920], [@b31-epj-09-5920], [@b39-epj-09-5920]), 3- HIV status (active, Inactive, recovered) ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b36-epj-09-5920], [@b39-epj-09-5920]), 4- test/diagnosis method ([@b20-epj-09-5920], [@b24-epj-09-5920], [@b36-epj-09-5920]), 5- Chief Complaint ([@b6-epj-09-5920], [@b21-epj-09-5920], [@b22-epj-09-5920], [@b24-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b34-epj-09-5920]), 6-Signs and Symptoms ([@b14-epj-09-5920], [@b19-epj-09-5920]--[@b24-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b30-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920], [@b39-epj-09-5920], [@b40-epj-09-5920]), 7- Physical examination ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b20-epj-09-5920], [@b24-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b33-epj-09-5920], [@b40-epj-09-5920]), 8- Assessment & Plan ([@b20-epj-09-5920], [@b24-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920]), 9- Body Mass Index ([@b19-epj-09-5920], [@b20-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b38-epj-09-5920]), 10-HIV staging (WHO classes) ([@b6-epj-09-5920], [@b20-epj-09-5920]--[@b22-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b30-epj-09-5920], [@b37-epj-09-5920], [@b39-epj-09-5920]), 11-HIV subtype (type one or two) ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b15-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920]), 12- Vital Signs ([@b6-epj-09-5920], [@b21-epj-09-5920]--[@b23-epj-09-5920], [@b34-epj-09-5920]), 13- medical procedures (related or unrelated to AIDS) ([@b6-epj-09-5920], [@b40-epj-09-5920]), 14-first sign/symptom onset date ([@b23-epj-09-5920], [@b24-epj-09-5920]), 15- HIV diagnosis date ([@b23-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920], [@b37-epj-09-5920]), 16- age of patient at the time of diagnosis ([@b18-epj-09-5920]), 17-the duration between being infected and the diagnosis ([@b16-epj-09-5920], [@b18-epj-09-5920])
  Prescription/ pharmaceutical information class     General prescription: 1- Prescription name ([@b6-epj-09-5920], [@b19-epj-09-5920]--[@b22-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b36-epj-09-5920]), 2-Drug form ([@b21-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b36-epj-09-5920]), 3-Consumption dose ([@b21-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b36-epj-09-5920]), 4-Consumption timing ([@b21-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b36-epj-09-5920]), 5-Route of administration ([@b21-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b36-epj-09-5920]) 6-Drug's target tissue ([@b21-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b36-epj-09-5920]), 7- Prescription date ([@b21-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b34-epj-09-5920], [@b35-epj-09-5920]), 8- Drug allergy ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b23-epj-09-5920], [@b34-epj-09-5920]), 9-Drug toxicity ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b23-epj-09-5920], [@b34-epj-09-5920]), 10-Drugs adverse effects ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b34-epj-09-5920]). Anti-Retrovirus Therapy / Anti Retrovirus (ART/ARV) summary: 1-current ART/ARV regime ([@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920]), 2-ART/ARV eligibility (date, reason) ([@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920]), 3-ART/ARV initiation (date, reason) ([@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920], [@b38-epj-09-5920]), 4-ART/ARV end (date, reason) ([@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920]), 5-ART/ARV discontinuation/ intermittent (date, reason ) ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920]), 6- ART/ARV alternative /changing (date, reason) ([@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920]), 7-ART/ARV dispense (date, reason) ([@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920]), 8-time between diagnosis and the ART initiation ([@b16-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920], [@b37-epj-09-5920]), 9- HIV stage at ART initiation ([@b20-epj-09-5920], [@b21-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920]), 10-CD4 and CD8 levels when starting the ART ([@b20-epj-09-5920], [@b25-epj-09-5920], [@b26-epj-09-5920], [@b34-epj-09-5920]), 11- Compliance/adherence assessments ([@b6-epj-09-5920], [@b16-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b37-epj-09-5920], [@b38-epj-09-5920])
  Laboratory information class                       1- HIV test name ([@b6-epj-09-5920], [@b20-epj-09-5920]--[@b22-epj-09-5920], [@b24-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b35-epj-09-5920], [@b37-epj-09-5920]), 2-HIV test type ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b24-epj-09-5920], [@b31-epj-09-5920], [@b36-epj-09-5920]), 3- Test normal range/reference ([@b20-epj-09-5920], [@b24-epj-09-5920], [@b32-epj-09-5920]), 4- Frequency of testing ([@b20-epj-09-5920], [@b32-epj-09-5920]), 5- First HIV test date ([@b20-epj-09-5920], [@b30-epj-09-5920], [@b32-epj-09-5920], [@b39-epj-09-5920]), 6- Related (sub) tests ([@b20-epj-09-5920]--[@b22-epj-09-5920], [@b32-epj-09-5920]), 7- HIV test result ([@b6-epj-09-5920], [@b21-epj-09-5920], [@b32-epj-09-5920]), 8- Date of first HIV test ([@b20-epj-09-5920], [@b32-epj-09-5920], [@b35-epj-09-5920]), 9-Date of first positive HIV test outcome ([@b20-epj-09-5920], [@b32-epj-09-5920], [@b35-epj-09-5920], [@b39-epj-09-5920]), 10- Date of last negative HIV test outcome ([@b20-epj-09-5920], [@b32-epj-09-5920]), 11-HIV/AIDS diagnosis date ([@b20-epj-09-5920], [@b32-epj-09-5920]), 12- Radiographic information ([@b6-epj-09-5920], [@b30-epj-09-5920], [@b33-epj-09-5920], [@b40-epj-09-5920]), 13-Specimen data (gathering date ([@b24-epj-09-5920], [@b36-epj-09-5920], [@b37-epj-09-5920]), type ([@b24-epj-09-5920], [@b36-epj-09-5920], [@b37-epj-09-5920]), quality ([@b24-epj-09-5920], [@b36-epj-09-5920], [@b37-epj-09-5920]), temperature ([@b24-epj-09-5920], [@b36-epj-09-5920], [@b37-epj-09-5920]), the date of receipt ([@b24-epj-09-5920], [@b36-epj-09-5920], [@b37-epj-09-5920]), interpretation date ([@b24-epj-09-5920], [@b36-epj-09-5920], [@b37-epj-09-5920]), result date ([@b20-epj-09-5920], [@b24-epj-09-5920], [@b32-epj-09-5920], [@b35-epj-09-5920], [@b36-epj-09-5920], [@b37-epj-09-5920])
  History information class                          1- Diseases/condition history ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b23-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b34-epj-09-5920], [@b39-epj-09-5920]), 2- Medication history (ART/non ART) ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b21-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b40-epj-09-5920]), 3- Procedure/ treatment history ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b40-epj-09-5920]), 4- High-risk sexual relationship history ([@b6-epj-09-5920], [@b20-epj-09-5920], [@b26-epj-09-5920]), 5-Pregnancy/delivery history ([@b20-epj-09-5920]), 6-Mental history ([@b20-epj-09-5920], [@b27-epj-09-5920], [@b28-epj-09-5920], [@b40-epj-09-5920]), 7-Social history ([@b20-epj-09-5920], [@b28-epj-09-5920], [@b36-epj-09-5920])
  Comorbidities/warning diseases information class   1- Tuberculosis ([@b20-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b38-epj-09-5920]), 2-Hepatitis ([@b18-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920]), 3- Sexually transmitted infections ([@b20-epj-09-5920], [@b22-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920]), 4-Cancer ([@b18-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920]), 5- Pneumonia ([@b18-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920]), 6- Opportunistic infections ([@b14-epj-09-5920], [@b18-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920], [@b33-epj-09-5920], [@b35-epj-09-5920]), 7-other ([@b20-epj-09-5920], [@b29-epj-09-5920], [@b30-epj-09-5920])
  Survival information class                         1- The current state of life ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920]), 2-Underlying cause of death ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920]), 3-Date of death ([@b6-epj-09-5920], [@b14-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920]), 4- The time between diagnosis and death ([@b16-epj-09-5920], [@b20-epj-09-5920]), 5-The time between initiation of the ART until death ([@b16-epj-09-5920], [@b20-epj-09-5920])

###### 

Necessary Data classes and elements for reporting with supportive purposes

  Information classes                     Data elements / References
  --------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Consulting program information class    Consult: 1- Behavioral ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b34-epj-09-5920]), 2- Family/family planning ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b34-epj-09-5920]), 3-Pregnancy / delivery ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b29-epj-09-5920], [@b34-epj-09-5920]), 4-Nutrition and diet therapy ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b34-epj-09-5920]), 5- Rehab ([@b20-epj-09-5920], [@b29-epj-09-5920], [@b34-epj-09-5920]), 6-Addiction ([@b20-epj-09-5920], [@b34-epj-09-5920]), 7-Occupational ([@b17-epj-09-5920], [@b20-epj-09-5920], [@b34-epj-09-5920]), 8-Prevention ([@b29-epj-09-5920], [@b34-epj-09-5920]), 9-Medication/timing of consumption ([@b20-epj-09-5920], [@b34-epj-09-5920]), 10-Before and after the first test ([@b34-epj-09-5920]), 11-Religious ([@b34-epj-09-5920]), 12-Marital ([@b34-epj-09-5920]), 13-Sexual behaviors ([@b34-epj-09-5920])
  Support programs information class      1-Charities ([@b29-epj-09-5920]), 2-Education and awareness programs ([@b29-epj-09-5920]), 3-Housing assistance ([@b29-epj-09-5920]), 4-Transportation assistance ([@b29-epj-09-5920]), 5-Isolation ([@b26-epj-09-5920], [@b29-epj-09-5920]), 6-screening ([@b20-epj-09-5920], [@b30-epj-09-5920], [@b31-epj-09-5920], [@b39-epj-09-5920]), 7-Social care services ([@b17-epj-09-5920], [@b29-epj-09-5920]), 8-Advocacy groups ([@b29-epj-09-5920], [@b31-epj-09-5920]), 9-Treatment supporter ([@b29-epj-09-5920]--[@b31-epj-09-5920])
  Subsidiary services information class   1-Laboratory services ([@b40-epj-09-5920]), 2-Imaging procedures ([@b40-epj-09-5920]), 3-Dental care ([@b40-epj-09-5920]), 4-mother/baby health ([@b40-epj-09-5920]), 5-Rehabilitation services ([@b29-epj-09-5920], [@b40-epj-09-5920]), 6-Immunization services ([@b20-epj-09-5920], [@b27-epj-09-5920]--[@b30-epj-09-5920], [@b36-epj-09-5920], [@b40-epj-09-5920]), 7-Preventive or prophylaxis services ([@b29-epj-09-5920]), 8-Contraceptive management ([@b39-epj-09-5920], [@b40-epj-09-5920]), 9-antenatal care ([@b40-epj-09-5920])
